✦ LIBER ✦

Results of a phase II trial with cystemustine in advanced malignant melanoma. A trial of the EORTC Clinical Screening Group

✍ Scribed by V. Urosevic; Ph. Chollet; A. Adenis; J. Chauvergne; P. Fargeot; H. Roche; P. Kerbrat; M.A. Lentz; P. Fumoleau; B. Chevallier

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of cystemustine in advanc

✍ P. Cappelaere; M.A. Lentz; M. Degardin; J. Chauvergne; F. Mayer; Ph. Chollet; B. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Taxotere in advanced malignant melanoma:

✍ Aamdal, S.; Verweij, J.; Piccart, M.; Bruntsch, U.; Paridaens, R.; Sulkes, A.; K 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Docetaxel (Taxotere) in advanced maligna

✍ Aamdal, S.; Wolff, I.; Kaplan, S.; Paridaens, R.; Kerger, J.; Schachter, J.; Wan 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 536 KB

N-(Phosphonacetyl)-l-aspartate (PALA) in

✍ Kleeberg, U.R.; Mulder, J.H.; Rümke, P.; Thomas, D.; Rozencweig, M. 📂 Article 📅 1982 🏛 Elsevier Science ⚖ 420 KB

Docetaxel (TaxotereTM) in advanced gastr

✍ Sulkes, A; Smyth, J; Sessa, C; Dirix, LY; Vermorken, JB; Kaye, S; Wanders, J; Fr 📂 Article 📅 1994 🏛 Nature Publishing Group 🌐 English ⚖ 745 KB

Results of a phase II trial with second-

✍ H. Curé; I. Krakowski; A. Adenis; N. Tubiana; P. Kerbrat; H. Roché; ✠B. Chevalli 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 45 KB